Presented at the ASTRO 2020 Annual Meeting, October 24 to October 28, 2020.
Brendon Stiles1,2, Leigh M. Boehmer3, Percy Lee4
1New York-Presbyterian Hospital, New York, NY, USA; 2Weill Cornell Medical Center, New York, NY, USA; 3Association of Community Cancer Centers, Rockville, MD, USA; 4Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
Multidisciplinary teams (MDTs) could help optimize quality of care by enhancing patient involvement in decision-making, timely care delivery, accurate staging, and appropriate treatment planning1.
Evolving treatment modalities for stage III and IV non-small cell lung cancer (NSCLC) warrants multidisciplinary collaborations2. Thoracic surgeons (TSs), radiation oncologists (ROs), and medical oncologists (MOs) as part of MDTs could play major roles in defining unresectability, diagnosis and treatment planning, and management of patients with inoperable stage III and stage IV NSCLC3,4.
A national survey of multidisciplinary specialists, including TSs, ROs, and MOs, was conducted to obtain insights into care of patients with advanced NSCLC across 160 U.S. community cancer programs.
ASCO Abstract: What Defines Quality Lung Cancer Care?
June 12, 2020
1. Osarogiagbon RU: Making the Evidentiary Case for Universal Multidisciplinary Thoracic Oncologic Care. Clin Lung Cancer 19:294-300, 2018
2. David EA, Clark JM, Cooke DT, et al: The Role of Thoracic Surgery in the Therapeutic Management of Metastatic Non-Small Cell Lung Cancer. J Thorac Oncol 12:1636-1645, 2017
3. National Comprehensive Cancer Network (NCCN) guidelines. 2020. https://www.nccn.org/store/login/login.aspx?ReturnURL=https://www.nccn. org/professionals/physician_gls/pdf/nscl.pdf. Accessed July 18, 2020.
4. Hait WN, Holland JF, Frei E III, et al: Principles of Medical Oncology, Holland‐Frei Cancer Medicine 1-9, 2017
This project is made possible by support from AstraZeneca.